Optimizing 2L HIV Treatment with DTG-based Regimens
A framework to support new product introduction in national health systems
Resource Library
- May 28, 2020
Leveraging ARV Optimization Opportunities to Unlock National Cost Savings
- May 19, 2020
Sustaining Critical Advanced HIV Disease Service Delivery During COVID-19 (English, French)
- May 12, 2020
2020 CHAI HIV Mid-Year Market Memo
- May 5, 2020
COVID-19 Evidence & Preparedness Recommendations for Pregnant Women, Infants, & Children
- Apr 2, 2020
COVID-19 Preparedness Recommendations for National HIV Testing and Lab Programs
- Mar 31, 2020
Preparing for COVID-19: Mobile Health Considerations
- Mar 31, 2020
COVID-19 & ART Counselling Guide for Healthcare Workers
- Mar 27, 2020
COVID-19 Checklist of Critical Actions for National HIV Programs (English, French)
- Mar 22, 2020
Preparing for COVID-19: Recommendations for National HIV Programs (English, French)
- Mar 1, 2020
Communique of the Kigali Community Meeting on Dolutegravir and Weight Gain
- Feb 4, 2020
CHAI Cost of Optimizing Second-Line Treatment (COST) Tool
- Jan 7, 2020
CHAI DTG Pregnancy Monitoring Tools
- Sep 20, 2019
2019 HIV Market Report
- Sep 20, 2019
Family Planning Resource Guide for HIV Healthcare Providers
- Jul 16, 2019
Access to ART and Integrated Family Planning Services in Zambia
- Jun 24, 2019
Viatris LPV/r Granule Job Aides
- Jun 3, 2019
Global Fund Sourcing and Management of Health Products
- Jun 3, 2019
WHO Prequalification Product List
- Jan 7, 2019
US FDA Approved and Tentatively Approved ARVs